Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The future for tiotropium.

P M Calverley1

  • 1University Hospital, Aintree, Liverpool, UK.

Chest
|February 16, 2000
PubMed
Summary
This summary is machine-generated.

Tiotropium, a new long-acting anticholinergic, offers potent bronchodilation for Chronic Obstructive Pulmonary Disease (COPD) patients. This once-daily maintenance treatment is well-tolerated, with ongoing research into its effects on quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017
Same author

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2016
Same author

Wood smoke exposure, poverty and impaired lung function in Malawian adults.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2011
Same author

Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients.

The European respiratory journal·2008
Same author

[Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease].

Revista portuguesa de pneumologia·2006
Same author

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.

Thorax·2005
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Pharmacology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) management and treatment require improvement.
  • Despite increased knowledge of COPD causes and progression, current therapeutic options remain suboptimal.

Purpose of the Study:

  • To evaluate the effectiveness and tolerability of Tiotropium as a novel maintenance treatment for COPD.
  • To assess the bronchodilator potential of Tiotropium in COPD patients.

Main Methods:

  • Analysis of spirometry data from clinical studies involving Tiotropium.
  • Evaluation of tolerability and safety profiles of Tiotropium treatment.

Main Results:

  • Tiotropium demonstrated potent bronchodilation in patients with COPD.

Related Experiment Videos

  • The drug was found to be very well tolerated in clinical studies.

    • Conclusions:

    • Tiotropium represents a significant advancement in COPD pharmacotherapy.
    • Further investigation is needed to fully understand Tiotropium's impact on patient health status and quality of life.